ArticleBMC psychiatry2026
Effects of nutritional supplementation on social impairment and behavioral dysregulation in autism spectrum disorder: a network meta-analysis.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAutism spectrum disorder (ASD) is characterized by core deficits in social interaction, often accompanied by behavioral challenges such as irritability and hyperactivity. In recent years, various nutritional supplements have been employed to alleviate ASD-related symptoms, yet the relative efficacy of different interventions remains unclear. This study employs network meta-analysis to compare the effects of distinct nutritional supplementation strategies on impaired social functioning and behavioral disorders in ASD.
methodsSystematically searched PubMed, Embase, Web of Science, and Cochrane Library databases for randomized controlled trials (RCTs) from indexing to December 20, 2025. Studies evaluating the effects of nutritional supplements on social functioning, irritability, and hyperactivity symptoms in children with ASD were included. A network meta-analysis using a random-effects model was conducted to calculate mean differences (MD) and 95% credible intervals (CrI). Interventions were ranked using SUCRA values. Data analysis was performed using R version 4.5.0.
resultsA total of 16 RCTs involving 736 children with ASD were included. The results of the network meta-analysis indicate that in terms of social functioning, Omega-3 [MD = - 2.29 (- 3.52, - 1.07)] and Vitamin D (VD) [MD = - 2.89 (- 5.08, - 0.72)] were associated with lower scores compared to UT, and both were superior to probiotics (Omega-3 vs. Probiotic: MD = - 1.74; VD vs. Probiotic: MD = - 2.34). For social functioning, the network estimates suggested that VD and omega-3 may be associated with lower symptom scores compared with usual treatment; however, these estimates were based on sparse and imprecise evidence. SUCRA rankings were calculated as exploratory indicators only and were not used to draw definitive conclusions regarding clinical superiority. For irritability, omega-3 and probiotics showed potentially favorable network estimates, whereas no clear intervention effect was observed for hyperactivity.
conclusionCurrent evidence does not support recommending any nutritional supplement over usual treatment for children with ASD. Although some network estimates suggested possible benefits for social functioning and irritability, these findings were limited by non-significant direct evidence, small sample sizes, sparse networks, heterogeneity, and imprecision. No clear effect was observed for hyperactivity. Further large, well-designed RCTs are needed. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.